Abstract
The goal of cancer therapy is to eliminate all cancer cells in a patient by surgery, radiation therapy, and/or chemotherapy. If residual cancer cells remain after therapy, the patient is more likely to have recurrent disease. Thus, detection of small amounts of residual cancer is predictive of relapse. Methods for detecting small amounts of cancer may include microscopy, cytogenetic studies, immunohistochemical or immunofluorescent staining, or sensitive molecular techniques. Although very sensitive methods are available to detect residual cancer, there is no agreement as to whether and how to treat patients with minimal residual disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
